Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 8 | 13 | 17 | 0 |
| Gross Profit | N/A | 8 | 13 | 17 | N/A |
| Operating Expenses | 12,796 | 2,102 | 3,123 | 2,922 | 2,300 |
| Operating Income | -12,796 | -2,094 | -3,109 | -2,905 | -2,300 |
| Interest Expense | 12 | 14 | 1 | 3 | 6 |
| Other Income | 61 | 96 | 60 | 63 | 68 |
| Pre-tax Income | -12,747 | -2,013 | -3,051 | -2,845 | -2,238 |
| Net Income Continuous | -12,747 | -2,013 | -3,051 | -2,845 | -2,238 |
| Net Income | $-12,747 | $-2,013 | $-3,051 | $-2,845 | $-2,238 |
| EPS Basic Total Ops | -162.46 | -25.53 | -45.35 | -42.34 | -29.43 |
| EPS Basic Continuous Ops | -166.05 | -25.66 | -45.24 | -38.74 | -29.46 |
| EPS Diluted Total Ops | -162.46 | -25.53 | -45.35 | -42.34 | -29.43 |
| EPS Diluted Continuous Ops | -166.05 | -25.66 | -45.24 | -38.74 | -29.46 |
| EBITDA(a) | $-12,796 | $-2,090 | $-3,098 | $-2,894 | $-2,287 |